Longtime Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics Post author:Sam Post published:December 3, 2017 Post category:BioPharma The COO of Seattle Genetics, Eric Dobmeier, is leaving the company to helm Silverback Therapeutics. Source: BioSpace You Might Also Like Medovex Corporation Receives CE Mark Approval For DenerveX System June 6, 2017 What Brent Saunders Thinks About a Possible Allergan Breakup October 19, 2017 Peregrine Slashes Workforce by 20% in Cost Cutting Plan August 10, 2017